Veeva Systems Inc. (VEEV) Stock Analysis — Fair Value, Risk & Moat Rating
NYQ · Healthcare · Health Information Services
Is Veeva Systems Inc. a safe investment right now?
Veeva Systems Inc.'s Altman Z-Score of 11.38 places it in the safe zone. Our fair value estimate is $174.08 (Watch Zone). Moat rating: 3.7/5 stars.
Could Veeva Systems Inc. go bankrupt? Altman Z-Score analysis
Z-Score of 11.38 is above 3.0, indicating the company is financially healthy by this metric.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives VEEV's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.7084 | 1.2 | 0.85 |
| B · Retained Earnings / Total Assets | RE / TA | 0.4859 | 1.4 | 0.68 |
| C · EBIT / Total Assets | EBIT / TA | 0.1021 | 3.3 | 0.34 |
| D · Market Cap / Total Liabilities | MCap / TL | 15.2571 | 0.6 | 9.15 |
| E · Revenue / Total Assets | Rev / TA | 0.3559 | 1.0 | 0.36 |
How has VEEV's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2023 | 17.0 | Safe |
| 2024 | 14.82 | Safe |
| 2025 | 12.86 | Safe |
| 2026 | 11.38 | Safe |
Source: Calculated from VEEV's latest 10-K filing on SEC EDGAR.
What is Veeva Systems Inc. actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $6.80 | Proprietary blend of reported actuals + analyst consensus, weighted by α |
| Last Year EPS | $5.44 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $8.84 | 29 analysts consensus |
| Trailing P/E | 30.1x | Current market pricing |
| Fair P/E (β discount) | 25.6x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Accelerating | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $265.83 (29 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Veeva Systems Inc. have a durable competitive advantage?
Moat rating: 3.7/5.
What makes up VEEV's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 4/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 4/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is VEEV's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2023 | 12.3% | — |
| 2024 | 9.2% | Declining |
| 2025 | 11.9% | Rising |
| 2026 | 12.7% | Stable |
Source: ROIC calculated from SEC EDGAR filings.
Is Veeva Systems Inc.'s dividend safe?
Veeva Systems Inc.'s key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $3.2B | $2.7B | $2.2B | Rising |
| Net Income | $0.9B | $0.7B | $0.5B | Rising |
| Free Cash Flow | $1.4B | $1.1B | $0.8B | Rising |
| Gross Margin | 75.5% | 74.5% | 71.7% | Rising |
Recent events that affect our VEEV analysis
VEEV earnings report scheduled
Upcoming report. Consensus EPS estimate: $2.14. Revenue estimate: $857.7M. Our current Fair Value: $174.08 — a significant beat or miss could shift this estimate.
VEEV analyst consensus: 71% bullish (22 of 31 analysts)
8 Strong Buy, 14 Buy, 8 Hold, 1 Sell, 0 Strong Sell. Consensus target: $265.83 (62.3% upside). Compare with our independent Fair Value: $174.08.
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
VEEV beat EPS estimates by 6.5%
Reported EPS: $2.06 vs estimate $1.94. Earnings strength supports our Fair Value of $174.08 (6.3% above current price).
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
VEEV beat EPS estimates by 4.5%
Reported EPS: $2.04 vs estimate $1.95. Earnings strength supports our Fair Value of $174.08 (6.3% above current price).
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
VEEV beat EPS estimates by 4.8%
Reported EPS: $1.99 vs estimate $1.90. Earnings strength supports our Fair Value of $174.08 (6.3% above current price).
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
VEEV beat EPS estimates by 13.0%
Reported EPS: $1.97 vs estimate $1.74. Earnings strength supports our Fair Value of $174.08 (6.3% above current price).
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VEEV beat EPS estimates by 10.1%
Reported EPS: $1.74 vs estimate $1.58. Earnings strength supports our Fair Value of $174.08 (6.3% above current price).
VEEV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Veeva Systems Inc.
What is Veeva Systems Inc. stock price today?
Veeva Systems Inc. (VEEV) stock price is $163.78 as of the latest market close, traded on the NYSE exchange.
What does Veeva Systems Inc. do?
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. It offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands.
What is Veeva Systems Inc. market cap?
Veeva Systems Inc. has a market capitalization of $26.92B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is VEEV in?
Veeva Systems Inc. operates in the Healthcare sector, specifically within the Health Information Services industry. It trades on the NYSE under the ticker symbol VEEV.
Is VEEV stock overvalued or undervalued?
Based on our valuation model, Veeva Systems Inc. trades 5.9% below our fair value estimate — potentially undervalued.
- FairValueLabs Fair Value: $174.08
- Current Price: $163.78
- Valuation Zone: Watch Zone
What is VEEV stock forecast and analyst target price?
Based on 29 Wall Street analysts, the consensus price target for Veeva Systems Inc. is $265.83, implying upside of 62.3% from the current price.
- Analyst High Target: $350.00
- Analyst Low Target: $176.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Veeva Systems Inc. revenue and earnings growing?
Here are the analyst consensus growth estimates for Veeva Systems Inc.:
- Revenue growth (current year est.): 12.7%
- EPS growth (current year est.): 9.2%
- Revenue growth (next year est.): 12.2%
- EPS growth (next year est.): 11.8%
What are Veeva Systems Inc.'s key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $3.2B | Rising |
| Net Income | $0.9B | Rising |
| Free Cash Flow | $1.4B | Rising |
| Gross Margin | 75.5% | Rising |
What is VEEV's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 30.1x
- Forward P/E (next 12 months est.): 16.6x
- FairValueLabs Fair P/E: 25.6x
How volatile is VEEV stock?
Veeva Systems Inc. has a beta of 1.10, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Veeva Systems Inc. have?
Veeva Systems Inc.'s balance sheet shows:
- Total Cash: $6.56B
- Total Debt: $95.9M
- Net Cash Position: $6.46B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is Veeva Systems Inc.'s free cash flow?
Veeva Systems Inc. generated $1.05B in trailing twelve-month free cash flow (from $1.42B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does Veeva Systems Inc. pay a dividend?
Veeva Systems Inc. does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.
Is Veeva Systems Inc. at risk of going bankrupt?
Veeva Systems Inc.'s Altman Z-Score is 11.38, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Veeva Systems Inc. have a durable competitive advantage?
Veeva Systems Inc. scores 3.7/5 stars (Solid moat · eroding) in our moat analysis:
- ROIC Stability: 4/5
- Gross Margin Trend: 4/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is VEEV's return on equity (ROE)?
Veeva Systems Inc.'s return on equity is 13.9%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy VEEV stock?
VEEV shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol VEEV
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is VEEV a value stock or speculative?
FairValueLabs classifies Veeva Systems Inc. as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of Veeva Systems Inc.?
The current CEO of Veeva Systems Inc. is Mr. Peter P. Gassner.
What is VEEV's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $5.44
- Forward EPS (next 12 months est.): $9.88
- Analyst consensus EPS (this year): $8.84
- Analyst consensus EPS (next year): $9.88
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
VEEV analysis methodology: How we calculate fair value, Z-Scores, and moat ratings